Coagulation FVIIa (Recombinant)

recombinant coagulation factor VIIa · rEVO Biologics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Coagulation FVIIa (Recombinant), covering 2017-06-14 to 2017-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors [Phase 3]

See pricing